In its upcoming report, BioMarin Pharmaceutical (BMRN) is predicted by Wall Street analysts to post quarterly earnings of $0.25 per share, reflecting a decline of 72.8% compared to the same period last year. Revenues are forecasted to be $829.66 million, representing a year-over-year increase of 11%.Over the last 30 days, there has been a downward revision of 2.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of ...

Wall Street analysts expect SPX Technologies (SPXC) to post quarterly earnings of $1.86 per share in its upcoming report, which indicates a year-over-year increase of 23.2%. Revenues are expected to be $627.44 million, up 17.6% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company announces its earn ...

Core Viewpoint - Analysts expect FMC Technologies (FTI) to report quarterly earnings of $0.51 per share, reflecting a year-over-year decline of 5.6%, while revenues are projected to be $2.55 billion, an increase of 7.6% from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.4% higher in the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Projections - Revenue from Subsea Technologies is expected to reach $2.23 billion, marking an 8.7% increase year-over-year [4] - Revenue from Surface Technologies is projected at $322 million, reflecting a 0.8% increase from the prior year [4] - Revenue from Lease is estimated at $71.31 million, indicating a significant increase of 24% year-over-year [4] - Revenue from Product is anticipated to be $922.80 million, showing an 8.3% increase from the previous year [5] Geographic Revenue Estimates - Revenue from Surface Technologies in Europe and Central Asia is expected to be $33.62 million, a 13.2% increase year-over-year [5] - Revenue from Surface Technologies in Africa is projected at $15.95 million, reflecting a 24.6% increase [6] - Revenue from Surface Technologies in North America is estimated at $105.63 million, indicating a decline of 1.6% from the prior year [6] - Revenue from Surface Technologies in the Middle East is expected to be $118.75 million, reflecting a decrease of 5% year-over-year [7] Order Backlog and Inbound Orders - The Order Backlog for Subsea Technologies is estimated at $16.31 billion, up from $13.52 billion year-over-year [8] - The total Order Backlog is projected to reach $17.06 billion, compared to $14.38 billion a year ago [8] - The Order Backlog for Surface Technologies is expected to be $728.81 million, down from $858.20 million year-over-year [8] - Inbound Orders for Subsea Technologies are forecasted to be $2.45 billion, down from $2.70 billion in the same quarter last year [7] Stock Performance - FMC Technologies shares have shown a return of +17.4% over the past month, outperforming the Zacks S&P 500 composite, which declined by -1.3% [10]

The upcoming report from Skyward Specialty Insurance (SKWD) is expected to reveal quarterly earnings of $0.93 per share, indicating an increase of 16.3% compared to the year-ago period. Analysts forecast revenues of $374 million, representing an increase of 22.9% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 2.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimate ...

Wall Street analysts expect Black Stone Minerals (BSM) to post quarterly earnings of $0.27 per share in its upcoming report, which indicates a year-over-year increase of 50%. Revenues are expected to be $104 million, up 24.2% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone an upward revision of 1.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Befo ...

Wall Street analysts forecast that CarGurus (CARG) will report quarterly earnings of $0.61 per share in its upcoming release, pointing to a year-over-year increase of 10.9%. It is anticipated that revenues will amount to $238.31 million, exhibiting an increase of 4.3% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Befo ...

Core Insights - The upcoming earnings report for American Homes 4 Rent (AMH) is projected to show quarterly earnings of $0.47 per share, reflecting a 4.4% increase year-over-year [1] - Analysts forecast revenues of $462.36 million, indicating a 5.9% year-over-year growth [1] Earnings Estimates - There has been a downward revision of 1% in the consensus EPS estimate for the quarter over the past 30 days, indicating a reappraisal by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock [3] Revenue Projections - Analysts expect 'Revenues- Same-Home core revenues' to be $358.48 million, representing a year-over-year increase of 7.1% [4] - The average prediction for 'Revenues- Tenant charge-backs' is $51.20 million, showing a 4.3% increase from the prior-year quarter [5] - 'Revenues- Core revenues' are expected to reach $407.79 million, reflecting a 5.2% increase from the previous year [5] - 'Revenues- Non-Same-Home core revenues' are projected at $49.31 million, indicating a decline of 6.6% from the prior-year quarter [5] Other Key Metrics - Analysts estimate 'Depreciation and amortization' to be $132.19 million [6] - Shares of American Homes 4 Rent have decreased by 2.3% over the past month, compared to a 1.7% decline in the Zacks S&P 500 composite [6] - AMH holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market [6]

Core Viewpoint - Epam (EPAM) is expected to report quarterly earnings of $3.16 per share, reflecting an 11.3% increase year-over-year, with revenues forecasted at $1.39 billion, representing an 11.4% year-over-year increase [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.4% in the past 30 days, indicating a reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates by Industry Verticals - Revenues from Financial Services are projected to be $331.55 million, indicating an 18% year-over-year increase [5]. - Software & Hi-Tech revenues are estimated at $202.43 million, reflecting an 11.2% year-over-year increase [5]. - Life Sciences & Healthcare revenues are expected to reach $166.16 million, suggesting a 9.3% year-over-year increase [6]. - Emerging Verticals revenues are projected at $233.81 million, indicating a 10.4% year-over-year increase [6]. - Consumer Goods, Retail & Travel revenues are expected to be $276.83 million, reflecting a 10.5% year-over-year increase [7]. Revenue Estimates by Contract Type - Time-and-material revenues are projected to reach $1.16 billion, indicating a 14.9% year-over-year increase [7]. - Fixed-price revenues are expected to be $223.21 million, reflecting a 4.5% year-over-year decrease [8]. - Licensing and other revenues are estimated at $10.92 million, suggesting a significant 56.6% year-over-year increase [8]. Revenue Estimates by Customer Location - Revenues from the Americas are projected to be $830.55 million, indicating a 10.2% year-over-year increase [9]. - APAC revenues are expected to reach $28.19 million, reflecting a 3.7% year-over-year increase [9]. - EMEA revenues are projected at $525.76 million, suggesting a 12.4% year-over-year increase [10]. Stock Performance - Over the past month, Epam shares have recorded a return of -24.2%, compared to a -2% change in the Zacks S&P 500 composite [10]. - Based on its Zacks Rank 2 (Buy), Epam is expected to outperform the overall market in the upcoming period [10].

Core Insights - Yelp Inc. reported better-than-expected fourth-quarter 2025 results with earnings of 61 cents per share, surpassing the Zacks Consensus Estimate by 29.1% despite a year-over-year decline of 1.6% from 62 cents [1][11] - The company's revenues decreased by 1% year over year to $360 million but exceeded the consensus mark by 0.5%, primarily due to a decline in advertising revenues [2][11] Financial Performance - Advertising revenues, which account for 94% of total revenues, fell by 2% year over year to $338 million, driven by a decrease in ad clicks [3][11] - The Services business saw advertising revenues grow by 2.9% year over year to $231.4 million, while the Restaurants, Retail & Other (RR&O) division's revenues dropped by 11.6% to $106.8 million due to macroeconomic challenges [4] - Total costs and expenses increased by 1% year over year to $311 million, with adjusted EBITDA plunging 15% to $86 million, resulting in a margin decrease from 28% to 24% [6] Balance Sheet and Cash Flow - As of December 31, 2025, Yelp held $319 million in cash and equivalents with no debt, generating an operating cash flow of $84.5 million and free cash flow of $72.3 million in the fourth quarter [7] Guidance - For Q1 2026, Yelp anticipates revenues between $350 million and $355 million, which is below the Zacks Consensus Estimate of $360.4 million and the previous year's revenues of $359 million [8][11] - For the full year 2026, the company expects revenues between $1.455 billion and $1.475 billion, compared to 2025 revenues of $1.465 billion and the consensus estimate of $1.5 billion [9]

Core Viewpoint - Insulet (PODD) is expected to report a quarterly earnings per share (EPS) of $1.48, marking a 28.7% increase year-over-year, with revenues projected at $767.33 million, reflecting a 28.4% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating that analysts have not revised their initial projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts predict 'Revenue- Total Omnipod' to be $765.48 million, indicating a year-over-year increase of 30.7% [5]. - The 'Revenue- Drug Delivery' is estimated to reach $0.97 million, which represents a significant decline of 91.8% from the previous year [5]. - The consensus for 'Revenue- International Omnipod' is set at $209.64 million, showing a year-over-year increase of 47.6% [5]. - 'Revenue- U.S. Omnipod' is expected to be $555.84 million, reflecting a year-over-year growth of 25.3% [6]. Stock Performance - Over the past month, Insulet shares have decreased by 11.3%, while the Zacks S&P 500 composite has only declined by 0.3% [6]. - Insulet currently holds a Zacks Rank of 4 (Sell), suggesting it may underperform the overall market in the near future [6].